Graphene quantum dots as potential broad-spectrum antiviral agents

Area of Science:

• Nanotechnology
• Virology
• Materials Science

Background:

• Emerging pandemic viruses pose significant global health threats.
• Current antiviral treatments like vaccines and antibodies face limitations due to viral mutations.
• A need exists for broad-spectrum antiviral agents targeting conserved viral structures.

Purpose of the Study:

• To investigate graphene quantum dots (GQDs) as a novel broad-spectrum antiviral agent.
• To evaluate the efficacy of GQDs against mutation-prone viral targets.
• To assess the safety profile of GQDs for potential therapeutic applications.

Main Methods:

• Synthesis and characterization of graphene quantum dots (GQDs).
• In vitro assessment of GQD antiviral activity against SARS-CoV-2 and influenza virus.
• Evaluation of GQD effects on viral infection and replication cycles.
• In vitro and in vivo cytotoxicity studies using cell lines and a mouse model.

Main Results:

• Graphene quantum dots (GQDs) demonstrated broad-spectrum antiviral activity.
• GQDs effectively disrupted viral membranes, inhibiting infection and replication of SARS-CoV-2 and influenza virus.
• Low cytotoxicity was observed in both cell line and mouse model studies, indicating a favorable safety profile.

Conclusions:

• Graphene quantum dots (GQDs) represent a promising universal first-line antiviral therapeutic strategy.
• The amphiphilic properties of GQDs offer a mutation-independent mechanism for viral inactivation.
• Further research into GQDs could lead to new treatments for a wide range of viral diseases.